{"count": 15, "results": [{"_id": "37921377", "pmid": 37921377, "title": "[Documento de consenso de la Sociedad Espanola de Obstetricia y Ginecologia (SEGO) y el Comite Espanol Interdisciplinario para la Prevencion Vascular (CEIPV). Ventana de oportunidad: prevencion del riesgo vascular en la mujer. Resultados adversos del embarazo y riesgo de enfermedad vascular.]", "journal": "Rev Esp Salud Publica", "authors": ["Goya M", "Miserachs M", "Suy Franch A", "Burgos J", "de la Calle M", "Brotons C", "Castellanos M", "Cortés Rico O", "Díaz Rodriguez Á", "Elosúa R", "Freijo MDM", "González Fondado M", "Gorostidi M", "Grau M", "Hernández Martínez AM", "Lahoz C", "Muñoz-Rivas N", "Pallares-Carratalá V", "Pedro-Botet J", "Rodilla E", "Goya E", "Royo Bordonada MÁ", "Santamaría R", "Torres Fonseca M", "Velescu A", "Zamora A", "Armario P"], "date": "2023-10-11T00:00:00Z", "meta_date_publication": "2023 Oct 11", "meta_volume": "97", "meta_issue": "", "meta_pages": "", "score": 50248.92, "text_hl": "Future studies evaluating the use of @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@, statins, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, among others, in women with a history of @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@APOs@@@ could strengthen recommendations regarding pharmacotherapy for primary prevention of @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@VD@@@ in these patients. ", "citations": {"NLM": "Goya M, Miserachs M, Suy Franch A, Burgos J, de la Calle M, Brotons C, Castellanos M, Cortés Rico O, Díaz Rodriguez Á, Elosúa R, Freijo MDM, González Fondado M, Gorostidi M, Grau M, Hernández Martínez AM, Lahoz C, Muñoz-Rivas N, Pallares-Carratalá V, Pedro-Botet J, Rodilla E, Goya E, Royo Bordonada MÁ, Santamaría R, Torres Fonseca M, Velescu A, Zamora A, Armario P. [Documento de consenso de la Sociedad Espanola de Obstetricia y Ginecologia (SEGO) y el Comite Espanol Interdisciplinario para la Prevencion Vascular (CEIPV). Ventana de oportunidad: prevencion del riesgo vascular en la mujer. Resultados adversos del embarazo y riesgo de enfermedad vascular.] Rev Esp Salud Publica. 2023 Oct 11;97():. PMID: 37921377", "BibTeX": "@article{37921377, title={[Documento de consenso de la Sociedad Espanola de Obstetricia y Ginecologia (SEGO) y el Comite Espanol Interdisciplinario para la Prevencion Vascular (CEIPV). Ventana de oportunidad: prevencion del riesgo vascular en la mujer. Resultados adversos del embarazo y riesgo de enfermedad vascular.]}, author={Goya M and Miserachs M and Suy Franch A and Burgos J and de la Calle M and Brotons C and Castellanos M and Cortés Rico O and Díaz Rodriguez Á and Elosúa R and Freijo MDM and González Fondado M and Gorostidi M and Grau M and Hernández Martínez AM and Lahoz C and Muñoz-Rivas N and Pallares-Carratalá V and Pedro-Botet J and Rodilla E and Goya E and Royo Bordonada MÁ and Santamaría R and Torres Fonseca M and Velescu A and Zamora A and Armario P}, journal={Rev Esp Salud Publica}, volume={97}}"}}, {"_id": "35089960", "pmid": 35089960, "pmcid": "PMC8797196", "title": "Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study", "journal": "PLoS One", "authors": ["Grindheim S", "Ebbing C", "Karlsen HO", "Skulstad SM", "Real FG", "Lønnebotn M", "Løvvik T", "Vanky E", "Kessler J"], "date": "2022-01-28T00:00:00Z", "doi": "10.1371/journal.pone.0262987", "meta_date_publication": "2022", "meta_volume": "17", "meta_issue": "1", "meta_pages": "e0262987", "score": 50248.723, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is prescribed to @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@) to prevent @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complications@@@. ", "citations": {"NLM": "Grindheim S, Ebbing C, Karlsen HO, Skulstad SM, Real FG, Lønnebotn M, Løvvik T, Vanky E, Kessler J. Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study PLoS One. 2022;17(1):e0262987. PMID: 35089960", "BibTeX": "@article{35089960, title={Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study}, author={Grindheim S and Ebbing C and Karlsen HO and Skulstad SM and Real FG and Lønnebotn M and Løvvik T and Vanky E and Kessler J}, journal={PLoS One}, volume={17}, number={1}, pages={e0262987}}"}}, {"_id": "35530948", "pmid": 35530948, "pmcid": "PMC9073771", "title": "Effects of metformin on pregnancy outcome, metabolic profile, and sex hormone levels in women with polycystic ovary syndrome and their offspring: a systematic review and meta-analysis", "journal": "Ann Transl Med", "authors": ["Zhu D", "Chen Y", "Huang J", "Deng H", "Shen X", "Lu D", "Xu L"], "date": "2022-04-01T00:00:00Z", "doi": "10.21037/atm-22-909", "meta_date_publication": "2022 Apr", "meta_volume": "10", "meta_issue": "7", "meta_pages": "418", "score": 50242.125, "text_hl": "Although the relative low quality of randomized controlled trials (RCTs) and limited results made it difficult to draw a definite conclusion, our study showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment during pregnancy can reduce the risk of @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complications@@@ but may have impacts on increasing @GENE_SHBG @GENE_6462 @@@SHBG@@@ levels and long-term BMI in offspring.", "citations": {"NLM": "Zhu D, Chen Y, Huang J, Deng H, Shen X, Lu D, Xu L. Effects of metformin on pregnancy outcome, metabolic profile, and sex hormone levels in women with polycystic ovary syndrome and their offspring: a systematic review and meta-analysis Ann Transl Med. 2022 Apr;10(7):418. PMID: 35530948", "BibTeX": "@article{35530948, title={Effects of metformin on pregnancy outcome, metabolic profile, and sex hormone levels in women with polycystic ovary syndrome and their offspring: a systematic review and meta-analysis}, author={Zhu D and Chen Y and Huang J and Deng H and Shen X and Lu D and Xu L}, journal={Ann Transl Med}, volume={10}, number={7}, pages={418}}"}}, {"_id": "26440203", "pmid": 26440203, "title": "Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis.", "journal": "Gynecol Endocrinol", "authors": ["Feng L", "Lin XF", "Wan ZH", "Hu D", "Du YK"], "date": "2015-01-01T00:00:00Z", "doi": "10.3109/09513590.2015.1041906", "meta_date_publication": "2015", "meta_volume": "31", "meta_issue": "11", "meta_pages": "833-9", "score": 50069.438, "text_hl": "Efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complications@@@ in @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@: a meta-analysis.", "citations": {"NLM": "Feng L, Lin XF, Wan ZH, Hu D, Du YK. Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2015;31(11):833-9. PMID: 26440203", "BibTeX": "@article{26440203, title={Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis.}, author={Feng L and Lin XF and Wan ZH and Hu D and Du YK}, journal={Gynecol Endocrinol}, volume={31}, number={11}, pages={833-9}}"}}, {"_id": "26651913", "pmid": 26651913, "title": "[Metformin and the obstetric patient].", "journal": "Ugeskr Laeger", "authors": ["Pedersen KD", "Bülow NS", "Aaboe K", "Galsgaard J", "Odgaard HS", "Mathiesen ER", "Lauenborg J"], "date": "2015-12-07T00:00:00Z", "meta_date_publication": "2015 Dec 7", "meta_volume": "177", "meta_issue": "50", "meta_pages": "V05150438", "score": 50067.66, "text_hl": "@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@Polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@) is associated with @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, @DISEASE_Infertility @DISEASE_MESH:D007246 @@@infertility@@@, @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and gestational complications. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is widely used in fertility treatment of @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, due to a suggested positive effect of continued @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment beyond the first trimester on @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complications@@@. ", "citations": {"NLM": "Pedersen KD, Bülow NS, Aaboe K, Galsgaard J, Odgaard HS, Mathiesen ER, Lauenborg J. [Metformin and the obstetric patient]. Ugeskr Laeger. 2015 Dec 7;177(50):V05150438. PMID: 26651913", "BibTeX": "@article{26651913, title={[Metformin and the obstetric patient].}, author={Pedersen KD and Bülow NS and Aaboe K and Galsgaard J and Odgaard HS and Mathiesen ER and Lauenborg J}, journal={Ugeskr Laeger}, volume={177}, number={50}, pages={V05150438}}"}}, {"_id": "30304773", "pmid": 30304773, "pmcid": "PMC6212814", "title": "AMP-Activated Protein (AMPK) in Pathophysiology of Pregnancy Complications", "journal": "Int J Mol Sci", "authors": ["Kumagai A", "Itakura A", "Koya D", "Kanasaki K"], "date": "2018-10-09T00:00:00Z", "doi": "10.3390/ijms19103076", "meta_date_publication": "2018 Oct 9", "meta_volume": "19", "meta_issue": "10", "meta_pages": "", "score": 50066.02, "text_hl": "AMP-Activated Protein (@GENE_PRKAA1 @GENE_5562 @@@AMPK@@@) in Pathophysiology of @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@Pregnancy Complications@@@", "citations": {"NLM": "Kumagai A, Itakura A, Koya D, Kanasaki K. AMP-Activated Protein (AMPK) in Pathophysiology of Pregnancy Complications Int J Mol Sci. 2018 Oct 9;19(10):. PMID: 30304773", "BibTeX": "@article{30304773, title={AMP-Activated Protein (AMPK) in Pathophysiology of Pregnancy Complications}, author={Kumagai A and Itakura A and Koya D and Kanasaki K}, journal={Int J Mol Sci}, volume={19}, number={10}}"}}, {"_id": "15178665", "pmid": 15178665, "title": "Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.", "journal": "Hum Reprod", "authors": ["Vanky E", "Salvesen KA", "Heimstad R", "Fougner KJ", "Romundstad P", "Carlsen SM"], "date": "2004-08-01T00:00:00Z", "doi": "10.1093/humrep/deh347", "meta_date_publication": "2004 Aug", "meta_volume": "19", "meta_issue": "8", "meta_pages": "1734-40", "score": 50063.066, "text_hl": "In the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated group we observed a reduction of severe, @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy and post-partum complications@@@. ", "citations": {"NLM": "Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004 Aug;19(8):1734-40. PMID: 15178665", "BibTeX": "@article{15178665, title={Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.}, author={Vanky E and Salvesen KA and Heimstad R and Fougner KJ and Romundstad P and Carlsen SM}, journal={Hum Reprod}, volume={19}, number={8}, pages={1734-40}}"}}, {"_id": "20465786", "pmid": 20465786, "pmcid": "PMC2885401", "title": "Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study", "journal": "Reprod Biol Endocrinol", "authors": ["Ott J", "Kurz C", "Nouri K", "Wirth S", "Vytiska-Binstorfer E", "Huber JC", "Mayerhofer K"], "date": "2010-05-13T00:00:00Z", "doi": "10.1186/1477-7827-8-45", "meta_date_publication": "2010 May 13", "meta_volume": "8", "meta_issue": "", "meta_pages": "45", "score": 50057.27, "text_hl": "By analyzing all @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complications@@@ together, the overall @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complication@@@ rate was highest in the CC group (70.0%, 28/40), followed by the LOD group (45.0%, 18/40), and the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ only group (47.5%, 19/40; p = 0.047).", "citations": {"NLM": "Ott J, Kurz C, Nouri K, Wirth S, Vytiska-Binstorfer E, Huber JC, Mayerhofer K. Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study Reprod Biol Endocrinol. 2010 May 13;8():45. PMID: 20465786", "BibTeX": "@article{20465786, title={Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study}, author={Ott J and Kurz C and Nouri K and Wirth S and Vytiska-Binstorfer E and Huber JC and Mayerhofer K}, journal={Reprod Biol Endocrinol}, volume={8}, pages={45}}"}}, {"_id": "17287476", "pmid": 17287476, "title": "Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.", "journal": "N Engl J Med", "authors": ["Legro RS", "Barnhart HX", "Schlaff WD", "Carr BR", "Diamond MP", "Carson SA", "Steinkampf MP", "Coutifaris C", "McGovern PG", "Cataldo NA", "Gosman GG", "Nestler JE", "Giudice LC", "Leppert PC", "Myers ER", "Cooperative Multicenter Reproductive Medicine Network"], "date": "2007-02-08T00:00:00Z", "doi": "10.1056/NEJMoa063971", "meta_date_publication": "2007 Feb 8", "meta_volume": "356", "meta_issue": "6", "meta_pages": "551-66", "score": 50050.21, "text_hl": "With the exception of @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complications@@@, adverse-event rates were similar in all groups, though @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@gastrointestinal side effects@@@ were more frequent, and @DISEASE_Rhinitis_Vasomotor @DISEASE_MESH:D012223 @@@vasomotor and ovulatory symptoms@@@ less frequent, in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group than in the @CHEMICAL_Clomiphene @CHEMICAL_MESH:D002996 @@@clomiphene@@@ group. ", "citations": {"NLM": "Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER, Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007 Feb 8;356(6):551-66. PMID: 17287476", "BibTeX": "@article{17287476, title={Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.}, author={Legro RS and Barnhart HX and Schlaff WD and Carr BR and Diamond MP and Carson SA and Steinkampf MP and Coutifaris C and McGovern PG and Cataldo NA and Gosman GG and Nestler JE and Giudice LC and Leppert PC and Myers ER and Cooperative Multicenter Reproductive Medicine Network}, journal={N Engl J Med}, volume={356}, number={6}, pages={551-66}}"}}, {"_id": "25588785", "pmid": 25588785, "pmcid": "PMC4298109", "title": "Efficacy of metformin in pregnant obese women: a randomised controlled trial", "journal": "BMJ Open", "authors": ["Chiswick CA", "Reynolds RM", "Denison FC", "Whyte SA", "Drake AJ", "Newby DE", "Walker BR", "Forbes S", "Murray GD", "Quenby S", "Wray S", "Norman JE"], "date": "2015-01-14T00:00:00Z", "doi": "10.1136/bmjopen-2014-006854", "meta_date_publication": "2015 Jan 14", "meta_volume": "5", "meta_issue": "1", "meta_pages": "e006854", "score": 50049.707, "text_hl": "We present a protocol for a study to test the hypothesis that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ will improve @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ pregnant @SPECIES_9606 @@@women@@@, thereby reducing the incidence of high birthweight babies and other @<m>DISEASE_Pregnancy_Complications</m> @DISEASE_MESH:D011248 @@@pregnancy complications@@@.", "citations": {"NLM": "Chiswick CA, Reynolds RM, Denison FC, Whyte SA, Drake AJ, Newby DE, Walker BR, Forbes S, Murray GD, Quenby S, Wray S, Norman JE. Efficacy of metformin in pregnant obese women: a randomised controlled trial BMJ Open. 2015 Jan 14;5(1):e006854. PMID: 25588785", "BibTeX": "@article{25588785, title={Efficacy of metformin in pregnant obese women: a randomised controlled trial}, author={Chiswick CA and Reynolds RM and Denison FC and Whyte SA and Drake AJ and Newby DE and Walker BR and Forbes S and Murray GD and Quenby S and Wray S and Norman JE}, journal={BMJ Open}, volume={5}, number={1}, pages={e006854}}"}}]}